Search Results

Ajay Narayanan studied oral cancer in the Northern Mariana Islands as part of the Global Health pathway at UT Southwestern Medical School.

A new immunotherapy drug combination has been dubbed a significant advancement in kidney cancer treatment. The combination of ipilimumab and nivolumab can improve outcomes and quality of life. Learn more.

Doctors and researchers are making strides every day in the fight against brain cancer. Read on to learn about some of the new developments underway at UT Southwestern.

UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice.

Manipulating dose, timing of therapies reduces relapse in cancer mouse models

Compassion in action: UTSW community celebrates giving with State Employee Charitable Campaign

A program that asks patients to mail in stool samples to screen for colon cancer is an effective way to expand screenings to underserved and underinsured communities and offers an alternative to in-person testing during the pandemic, according to a study conducted by UT Southwestern.

Ten scientists in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have been awarded nearly $15 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to advance research on a wide range of cancer issues.

A team of investigators used intraoperative infusions of labeled glucose in patients about to have surgery to remove the kidney cancer to assess how the tumors use glucose.

Simmons Comprehensive Cancer Center at UT Southwestern received more than $5 million in research funding in the latest round of grants awarded by the Cancer Prevention and Research Institute of Texas (CPRIT).